Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorTanta University
About this trial
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Eligibility criteria
Qualifiers
Age from 18 to 40 years.
American Society of Anesthesiology (ASA) physical status II.
Parturient women undergoing cesarean section under spinal anesthesia.
Disqualifiers
Parturient women with any contraindication or hypersensitivity to the study drugs.
Any history of cardiovascular diseases, psychosis, hypertension, fetal distress, cord prolapse initial.
Preoperative shivering.
Preoperative fever (>38°C).
Trial design
Treatments tested in this trial
- Ondansetron lozenge
- Ondansetron intravenous
Treatment groups
90 Participants
are divided into 3 treatment groupsLocations
1Tanta University31527, TantaEl-Gharbia, Egypt
Sponsors and collaborators
Tanta University
Lead sponsor
Source ClinicalTrials.gov